Frommer Can Defend Par In Rythmol Suit: Judge

Reliant Pharmaceuticals Inc. lost a bid on Thursday to disqualify Frommer Lawrence & Haug LLP from defending Par Pharmaceuticals Inc. in a patent lawsuit over Reliant's heart drug Rythmol SR on...

Already a subscriber? Click here to view full article